首页> 外文期刊>European journal of pharmaceutical sciences >Hepatoprotective effects of AdipoRon against D-galactosamine-induced liver injury in mice
【24h】

Hepatoprotective effects of AdipoRon against D-galactosamine-induced liver injury in mice

机译:AdipoRon对D-半乳糖胺诱导的小鼠肝损伤的肝保护作用

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Adiponectin is an antidiabetic and antiatherogenic adipokine, which plays distinct roles in the balance of energy homoeostasis. As an insulin sensitizing hormone, adiponectin exerts multiple biological effects by the specific receptors (AdipoR1 and AdipoR2), through activation of AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor (PPAR)a pathways. AdipoRon, an orally active synthetic small-molecule AdipoR agonist, shows very similar effects to adiponectin in vitro and in vivo, which could be a promising therapeutic approach for obesity-related disorders. In view of the regulatory effects of adiponectin or AdipoRon on inflammatory response and energy metabolism, they might be endowed a curative potential for tissue damage. Hence, its effects and possible mechanism were investigated. In vitro studies on hepatocytes (L02) and macrophages (RAW264.7) suggested a protective and anti-inflammatory potential of AdipoRon. The effects were verified in acute hepatic injury mice induced by D-galactosamine (D-GalN); hepatic lesions were restored by AdipoRon or bicyclol (positive reference drug) pretreatment, which were characterized by a significant increase in serological and hepatic biomarkers (AST, ALT, MDA and NOSs). Besides, AdipoRon attenuated the inflammation in the liver, characterized by the dwindling proinflammatory macrophage infiltration, as well as the shrinkage of tumor necrosis factor-alpha (TNF-alpha), transforming growth factor beta 1 (TGF-beta 1), interleukin-1 beta (1L-1 beta) and interleukin-6 (IL-6); meanwhile conversely promoted AMPK activation by phosphorylation. Combined with liver histopathology, these results demonstrated the hepatoprotective effects of AdipoRon against D-GalN-induced damage, which might be ascribed to the attenuation of inflammation, inhibition of free radical reactions, as well as enhancement of liver energy metabolism. (C) 2016 Elsevier B.V. All rights reserved.
机译:脂联素是一种抗糖尿病和抗动脉粥样硬化的脂肪因子,在能量平衡方面起着独特的作用。脂联素作为一种胰岛素敏感性激素,通过激活AMP激活的蛋白激酶(AMPK)和过氧化物酶体增殖物激活的受体(PPAR)a途径,通过特定的受体(AdipoR1和AdipoR2)发挥多种生物学作用。口服活性合成小分子AdipoR激动剂AdipoRon在体外和体内显示与脂联素非常相似的作用,这可能是肥胖相关疾病的一种有前途的治疗方法。考虑到脂联素或脂联素对炎症反应和能量代谢的调节作用,它们可能具有治愈组织损伤的潜力。因此,研究了其作用和可能的机理。对肝细胞(L02)和巨噬细胞(RAW264.7)的体外研究表明,AdipoRon具有保护和抗炎的潜力。在D-半乳糖胺(D-GalN)诱导的急性肝损伤小鼠中证实了这种作用;肝损伤可通过AdipoRon或双环醇(阳性参考药物)预处理恢复,其特征是血清和肝生物标志物(AST,ALT,MDA和NOSs显着增加)。此外,AdipoRon减轻了肝脏的炎症,其特征在于促炎性巨噬细胞浸润的减少,以及肿瘤坏死因子-α(TNF-α)的萎缩,转化生长因子β1(TGF-β1),白介素-1 beta(1L-1 beta)和IL-6(IL-6);同时相反地通过磷酸化促进了AMPK的活化。结合肝脏组织病理学,这些结果证明了AdipoRon对D-GalN诱导的损伤的肝保护作用,这可能归因于炎症的减轻,自由基反应的抑制以及肝能量代谢的增强。 (C)2016 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号